Venture

Primacorp Ventures Inc. Donates $50,000 to Revitalize Important Refugee and Immigration Conference

Retrieved on: 
Tuesday, October 31, 2023
Parliament, Woman, CCIS, CDI College, Immigration, Refugees and Citizenship Canada, Education, CDI, Government, Refugee, RAP, Gender equality, Reeves College, Conference, Organization, Venture, Vancouver College of Art and Design, Vancouver Career College, Business, Immigration, Art, Future, Immigration to Canada, IRCC, Nursing, Pharmaceutical industry

This fund has been used to organize the Resettlement Assistance Program (RAP) Conference in Peterborough, Ontario, on October 16 – 18, in collaboration with Refugee, Immigration and Citizenship Canada (IRCC).

Key Points: 
  • This fund has been used to organize the Resettlement Assistance Program (RAP) Conference in Peterborough, Ontario, on October 16 – 18, in collaboration with Refugee, Immigration and Citizenship Canada (IRCC).
  • Primacorp Ventures has greatly supported refugees and immigrants through its various scholarship programs with CDI College and other colleges.
  • The conference facilitated numerous side meetings between Primacorp Ventures and the executive directors and senior officials of non-profit organizations and the federal government agency.
  • Primacorp Ventures also donated $30,000 to the Calgary Catholic Immigration Society (CCIS) to organize the Resettlement Assistance Program Conference in Calgary in December 2022.

Bioluminescence Ventures Emerges from Stealth with $477M AUM

Retrieved on: 
Wednesday, November 1, 2023
Health, Genetics, Research, Pharmaceutical, Science, Biotechnology, Biomedical Research, IPO, Heart, Therapy, Like a Boss (film), BLV, Venture, Environment, Metaphor, COVID-19, Patient, Perception, Biomedical engineering, Pharmaceutical industry

Bioluminescence Ventures (“BLV”), a biotech venture firm investing in next-generation medicines, today announced its emergence from stealth with $477M in assets under management across two funds: Bioluminescence Ventures Fund I, L.P., and Bioluminescence Ventures Fund II, L.P.

Key Points: 
  • Bioluminescence Ventures (“BLV”), a biotech venture firm investing in next-generation medicines, today announced its emergence from stealth with $477M in assets under management across two funds: Bioluminescence Ventures Fund I, L.P., and Bioluminescence Ventures Fund II, L.P.
  • The firm is supported by an investor base that includes U.S. and multinational institutional Limited Partners.
  • The firm will continue investing in transformative companies that are developing preventative, disease-modifying, and curative treatments for patients with major unmet medical needs.
  • “We aim to support them with our time, energy, interdisciplinary expertise, and capital to make that light shine brighter.”

Allegion Ventures Invests in Ambient.ai

Retrieved on: 
Monday, October 30, 2023
Technology, Mobile, Wireless, Audio, Video, Manufacturing, Finance, Banking, Professional Services, Artificial Intelligence, Software, Internet, Hardware, Other Manufacturing, Security, Consumer Electronics, Intelligence, Rock (geology), History, Marten, Design for additive manufacturing, Venture, Artificial intelligence, Partnership, Trailblazer, AI, Deep learning, CVI, Management, Allegion

Allegion Ventures – the corporate venture fund of Allegion plc – has made a $20 million investment in Ambient.ai , the artificial intelligence (AI) powered computer vision intelligence (CVI) company that’s transforming enterprise security operations to prevent security incidents before they happen.

Key Points: 
  • Allegion Ventures – the corporate venture fund of Allegion plc – has made a $20 million investment in Ambient.ai , the artificial intelligence (AI) powered computer vision intelligence (CVI) company that’s transforming enterprise security operations to prevent security incidents before they happen.
  • Allegion President and CEO John H. Stone said Ambient.ai aligns with Allegion’s focus on using innovative technology to enable seamless access and a safer world.
  • “This is the largest and most significant investment in the history of Allegion Ventures, reflecting the tremendous potential we see for future collaboration between Ambient.ai and Allegion,” Stone said.
  • “Allegion’s best-in-class products bring exciting possibilities to the table as we continue to deliver compelling solutions to prevent even the most complex security incidents.”
    Additional terms of the Allegion Ventures deal have not been disclosed.

ACLARITY SECURES $16M IN SERIES A FUNDING TO DEPLOY LOW ENERGY PFAS "FOREVER CHEMICAL" DESTRUCTION SOLUTION

Retrieved on: 
Thursday, November 2, 2023
Attention, Water, Frost, Health, Food, Venture, Nature, Environment, Growth, PFBS, Year's Best SF 15, Public, Series, PFA, Cosmetics, Renewable energy, Aclare, PFAS

This funding round was led by Aqualateral , with participation from HG Ventures, Bidra Innovation Ventures, Nor'easter Ventures, MassVentures, and Burnt Island Ventures.

Key Points: 
  • This funding round was led by Aqualateral , with participation from HG Ventures, Bidra Innovation Ventures, Nor'easter Ventures, MassVentures, and Burnt Island Ventures.
  • Over the last year, Aclarity has deployed mobile systems with full-scale reactors across the country to destroy PFAS chemicals continuously.
  • Aclarity's innovative approach to PFAS destruction has garnered attention and support from both investors and environmental advocates alike.
  • For more information about Aclarity and its PFAS destruction technology, please visit www.aclaritywater.com

ImmPACT Bio Appoints Han Lee, Ph.D., MBA, as President and Chief Financial Officer

Retrieved on: 
Tuesday, October 31, 2023
CAR, AstraZeneca, Biotechnology, Genetics, Acquisition, MBA, Venture, Yale University, Growth, Partnership, CFO, Cancer, Investment, Corporate development, Management

LOS ANGELES, Oct. 31, 2023 /PRNewswire/ -- ImmPACT Bio USA, Inc. ("ImmPACT Bio"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR) T-cell therapies for treating cancer and autoimmune diseases, today announced the appointment of Han Lee, Ph.D., MBA, as president and chief financial officer (CFO).

Key Points: 
  • LOS ANGELES, Oct. 31, 2023 /PRNewswire/ -- ImmPACT Bio USA, Inc. ("ImmPACT Bio"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR) T-cell therapies for treating cancer and autoimmune diseases, today announced the appointment of Han Lee, Ph.D., MBA, as president and chief financial officer (CFO).
  • An accomplished biotechnology executive, Dr. Lee joins ImmPACT Bio with more than 10 years of corporate finance, strategy, business development, and company building experience in the biopharmaceutical industry.
  • "We are thrilled to welcome Han, a seasoned CFO to ImmPACT Bio's executive leadership.
  • This is a pivotal time for ImmPACT Bio with compelling clinical data expected within the next 12 months.

Revv emerges from stealth to diagnose advanced driver assistance systems (ADAS) for automotive repair shops

Retrieved on: 
Monday, October 23, 2023
Soma, Documentation, OEM, Insurance, Calibration, LLM, Walmart, ADAS, CCC, Microsoft, Venture, ROI, Bathala, VIN, EMS, Traction, Safety, Pinterest, Mechanics, Automation, Video game, Cryptocurrency, Gunsmith, Online shopping, Revv Cars

Revv’s platform leverages AI to help mechanics and service technicians easily diagnose hard-to-identify issues with a car's advanced driver assistance systems (ADAS), boosting shop revenue and ensuring safety for drivers.

Key Points: 
  • Revv’s platform leverages AI to help mechanics and service technicians easily diagnose hard-to-identify issues with a car's advanced driver assistance systems (ADAS), boosting shop revenue and ensuring safety for drivers.
  • Yet according to Revv’s data, 60% of repair estimates by auto repair shops don’t include ADAS repairs, meaning essential fixes aren’t being made.
  • This makes it a potential safety hazard for customers and a missed revenue-generating opportunity for shops.
  • Streamlined workflows: RevvADAS integrates with shops’ existing systems to easily identify necessary ADAS calibrations from repair estimates.

NANBAN VENTURES LLC INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation into NANBAN VENTURES LLC and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

Retrieved on: 
Friday, October 20, 2023
Sakthivel, Venture, Complaint, LLP, Hindenburg, Hindenburg Research

Details of the alleged fraud were published in a report by Hindenburg Research entitled, “Nanban Ventures: With ‘Friends’ Like These…,” on October 17, 2023.

Key Points: 
  • Details of the alleged fraud were published in a report by Hindenburg Research entitled, “Nanban Ventures: With ‘Friends’ Like These…,” on October 17, 2023.
  • If you have information that could assist in the Nanban Investigation or if you are an Nanban investor who suffered a loss and would like to learn more, you can provide your information HERE .
  • THE WRONGDOING: The individuals, through the “Nanban” companies, raised at least $129.7 million by using allegedly fraudulent securities offerings.
  • On October 5, 2023, the United States Securities and Exchange Commission filed a Complaint against the above-referenced parties alleging a variety of legal claims.

Aviapartner Extends Footprint Through Joint Venture With South Africa

Retrieved on: 
Saturday, October 21, 2023
Other Travel, Air, Transportation, Transport, Travel, Venture, Lufthansa, South African Airways, Safety, Acquisition, Airlink, Royal Commission into Aged Care Quality and Safety, Joint venture, Partnership, Aircraft, Airport, Airline, Ethiopian Airlines, Aviapartner, African, British Airways

Aviapartner, leading Airport Ground Services group in Europe, enters a Joint Venture with Colossal to serve airlines and passengers in South Africa.

Key Points: 
  • Aviapartner, leading Airport Ground Services group in Europe, enters a Joint Venture with Colossal to serve airlines and passengers in South Africa.
  • Aviapartner will control 51% of the new Joint Venture.
  • With this acquisition, Aviapartner gains a presence in South Africa, supported by Colossal.
  • This Joint Venture allows us to enter the South African market and to offer the same Quality and Safety already provided to passengers and airliners at leading European airports.

Hengde Qin named Chief Financial Officer of Syngenta Group

Retrieved on: 
Friday, October 20, 2023
Environment, Technology, Climate Change, Finance, Professional Services, Food, Beverage, Agriculture, Retail, Natural Resources, Food Tech, Knowledge, CNAC, Crop protection, Lichtenstein, Global Operations, Shenzhen Stock Exchange, Multimedia, Syngenta, CFO, Integration, SGC, Management, ChemChina, Venture

Syngenta Group’s Board of Directors has named Hengde Qin, 53, Chief Financial Officer of Syngenta Group, effective Dec 1, 2023.

Key Points: 
  • Syngenta Group’s Board of Directors has named Hengde Qin, 53, Chief Financial Officer of Syngenta Group, effective Dec 1, 2023.
  • View the full release here: https://www.businesswire.com/news/home/20231020464279/en/
    Hengde Qin, Chief Financial Officer of Syngenta Group as of Dec 1, 2023.
  • (Photo: Business Wire)
    Fanrong Li, Chairman of Syngenta Group said, “Hengde is a strong leader with excellent financial acumen.
  • Qin is currently the Chief Human Resources Officer of Syngenta Group, based in Basel, a position that he assumed at the beginning of the year.

Leading Live Event E-Commerce Company Tixr Honored by Goldman Sachs for Entrepreneurship

Retrieved on: 
Wednesday, October 18, 2023
Goldman Sachs, 2021 Acura Grand Prix of Long Beach, Lightning, NYSE, Riot Fest, Golf, Dragoneer Investment Group, Summit, Venture, LIV Golf, Portland Trail Blazers, GS, World Innovation Summit for Education, Commerce, Security (finance), Boilermaker

SANTA MONICA, Calif., Oct. 18, 2023 /PRNewswire-PRWeb/ -- Tixr Co-Founder & CEO Robert Davari Among the Most Exceptional Entrepreneurs at 2023 Builders and Innovators Summit,

Key Points: 
  • Today, Goldman Sachs (NYSE:GS) is recognizing Tixr CEO & Co-Founder Robert Davari as one of the Most Exceptional Entrepreneurs of 2023.
  • "It's an amazing feeling for me and the entire team at Tixr to be recognized by Goldman Sachs for our contributions in this competitive space."
  • - Robert Davari, CEO of Tixr
    Goldman Sachs selected Robert Davari from multiple industries to be honored at the two-day event.
  • Co-founded and led by Davari, Tixr came on the scene in 2013 and has since become the world's largest, fastest-growing privately-held primary ticketing and live event commerce marketplace.